Zoetis (ZTS) Tops Q4 EPS by 5c; Guides FY21 Higher

Zoetis (NYSE: ZTS) reported Q4 EPS of $0.91, $0.05 better than the analyst estimate of $0.86. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.73 billion.

GUIDANCE:

Zoetis sees FY2021 EPS of $4.36-$4.46, versus the consensus of $4.26. Zoetis sees FY2021 revenue of $7.4-7.55 billion, versus the consensus of $7.11 billion.

For earnings history and earnings-related data on Zoetis (ZTS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c